Journal of Maxillofacial and Oral Surgery

, Volume 17, Issue 2, pp 201–206 | Cite as

Comparison of Ropivacaine 0.75 % and Lignocaine 2 % with 1:200,000 Adrenaline in Dental Extractions: Single Blind Clinical Trial

  • Vishal Bansal
  • Deval Kumar
  • Apoorva Mowar
  • Avi Bansal
Comparative Study



The aim of this study was to evaluate the efficacy, safety and clinical acceptability of the local anaesthetic agent ropivacaine 0.75 % in comparison with lignocaine 2 % with adrenaline 1:200,000 in minor oral surgical procedures.


Forty-seven patients, who required bilateral extractions in a single arch, were included in this study. One hundred and sixty-six extractions were performed and all the patients were administered nerve blocks/infiltration. Pre and postoperative pulse, blood pressure, random blood sugar, electrocardiogram and partial oxygen pressure were recorded at specified time intervals. Pain score by visual analogue scale, onset of action and depth of anesthesia were also observed. Duration of anaesthesia was assessed by feeling of numbness and first sign of pain.


Statistical analysis revealed insignificant difference between both the groups in terms of pulse, blood pressure, random blood sugar, and partial oxygen pressure. The depth of anesthesia was evaluated by pain, comfort during the procedure with visual analog scale and showed no significant difference between the two groups. The onset of action for maxillary infiltration was 33.29 ± 9.2 (ropivacaine), 32.12 ± 6.8 s (2 % lignocaine with adrenaline 1:200,000) and for pterygomandibular nerve block was 181.0 ± 87.5 (ropivacaine), 32.12 ± 6.8 s (2 % lignocaine with adrenaline 1:200,000). Duration of anesthesia when compared was 411.7 ± 66.11 min (ropivacaine) and 107.87 ± 16.54 (2 % lignocaine with adrenaline 1:200,000). On maxillary buccal vestibule infiltration it was also observed that in ropivacaine group there was no requirement of palatal infiltration suggestive of good diffusion property.


Ropivacaine is a safe, clinically acceptable long acting local anaesthetic agent with added advantage of effective diffusion property.

Ethical Committee Approval Number



Ropivacaine Lignocaine with adrenaline Cardiovascular system Central nervous system Random blood sugar Diffusion property 



Local anaesthesia


Local anaesthesia with adrenaline


Cardiovascular system


Central nervous system


Random blood sugar


Blood pressure


Partial oxygen pressure




Visual analog scale


Compliance with Ethical Standards

The study was approved by institutional Ethical committee vide letter no. SDC/MISC/2013/239 dated 24.01.2013.


  1. 1.
    Malamed SF (2004) Handbook of local anesthesia. Chapter 4, Clinical action of specific agents, 5th edn. Elsevier, California, pp 61–65Google Scholar
  2. 2.
    Oliveira NE, Lima Filho NS, Lima EG, Vasquez EC (2006) Effects of regional anesthesia with ropivacaine on arterial pressure and heart rate in healthy subjects. Eur J Oral Sci 114(1):27–32CrossRefPubMedGoogle Scholar
  3. 3.
    Sawaki K, Okubo M, Shimomiya T et al (2009) Evaluation of high performance liquid chromatography and mass spectrometry method for pharmacokinetic study of local anesthetic ropivacaine in plasma. Biomed Res 30(6):319–324CrossRefPubMedGoogle Scholar
  4. 4.
    Hassan S, Rao S, Sequeria J, Rai G (2011) Efficacy of 4% articaine hydrochloride and 2% lignocaine in extraction of maxillary premolars for orthodontic extractions. Ann Maxillofac Surg 1(1):14–18CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kopacz DJ, Carpenter RL, Mackey DC (1989) Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology 71(1):69–74CrossRefPubMedGoogle Scholar
  6. 6.
    Dahl JB, Simonsen L, Mogensen T, Henriksen JH, Kehlet H (1990) The effect of 0.5% ropivacaine on epidural blood flow. Acta Anaesthesiol Scand 34(4):308–310CrossRefPubMedGoogle Scholar
  7. 7.
    Weber A, Fournier R, Van E, Riand N, Gamulin Z (2001) Epinephrine does not prolong the anesthesia of 20 ml ropivacaine 0.5% or 0.2% in a femoral three in one block. Anesth Analg 93:1327–1331CrossRefPubMedGoogle Scholar
  8. 8.
    Reiz S, Haggmark S, Johansson G, Nath S (1989) Cardio-toxicity of ropivacaine—a new amide local anesthetic agent. Acta Anaesthesiol Scand 33:93–98CrossRefPubMedGoogle Scholar
  9. 9.
    Stewart J, Kellett N, Castro D (2003) The central nervous system and cardiovascular effects of levobupivacaine and ropivacaine in healthy volunteers. Anesth Analg 97(2):412–416CrossRefPubMedGoogle Scholar
  10. 10.
    Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Edvardsson N (1997) Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 78(5):507–514CrossRefPubMedGoogle Scholar
  11. 11.
    Atanassoff PG, Hartmannsgruber MW (2002) Central nervous system side effects are less important after iv regional anesthesia with ropivacaine 0.2% compared to lidocaine 0.5% in volunteers. Can J Anaesth 49(2):169–172CrossRefPubMedGoogle Scholar
  12. 12.
    Kalra P, Rana AS, Peravali RK, Gupta D, Jain G (2011) Comparative evaluation of local anaesthesia with adrenaline and without adrenaline on blood glucose concentration in patients undergoing tooth extractions. J Maxillofac Oral Surg 10(3):230–235CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Meechan JG (1991) The effects of dental local anaesthetics on blood glucose concentration in healthy volunteers and in patients having third molar surgery. Br Dent J 170(10):373–376CrossRefPubMedGoogle Scholar
  14. 14.
    Axelsson S, Icsacsson G (2004) The efficacy of ropivacaine as a dental local anesthetic. Swed Dent J 28:85–91PubMedGoogle Scholar
  15. 15.
    Lima J, Ribeiro E, Araujo T, Rocha J, Honfi J, Samento C et al (2009) Evaluation of the buccal vestibule-palatal diffusion of 4% articaine hydrochloride in impacted maxillary third molar extractions. Med Oral Patol Oral Cir Bucal 14(3):E129–E132Google Scholar
  16. 16.
    Kumaresan R, Srinivasan B, Pendayala S (2015) Comparison of the effectiveness of lidocaine in permanent maxillary teeth removal performed with single buccal infiltration versus routine buccal and palatal injection. J Maxillofac Oral Surg 14(2):252–257CrossRefPubMedGoogle Scholar
  17. 17.
    Kennedy M, Reader A, Beck M, Weaver J (2001) Anesthetic efficacy of ropivacaine in maxillary anterior infiltration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91(4):406–412CrossRefPubMedGoogle Scholar
  18. 18.
    Ernberg M, Kopp S (2002) Ropivacaine for dental anesthesia: a dose-finding study. J Oral Maxillofac Surg 60(9):1004–1010 (1010-1011) CrossRefPubMedGoogle Scholar
  19. 19.
    McNaught A, Shastri U, Carmichael N, Awad IT, Columb M, Cheung J, Holtby RM, McCartney CJ (2011) Ultrasound reduces the minimum effective local anaesthetic volume compared with peripheral nerve stimulation for interscalene block. Br J Anaesth 106(1):124–130CrossRefPubMedGoogle Scholar

Copyright information

© The Association of Oral and Maxillofacial Surgeons of India 2016

Authors and Affiliations

  • Vishal Bansal
    • 1
  • Deval Kumar
    • 2
  • Apoorva Mowar
    • 1
  • Avi Bansal
    • 1
  1. 1.Department of Oral and Maxillofacial SurgerySubharti Dental CollegeMeerutIndia
  2. 2.Private PracticeRoorkeeIndia

Personalised recommendations